SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001104659-18-049177
Filing Date
2018-08-02
Accepted
2018-08-02 16:05:39
Documents
1
Group Members
VEF MANAGEMENT V, LLCVENROCK ENTREPRENEURS FUND V, L.P.VENROCK HEALTHCARE CAPITAL PARTNERS II, L.P.VENROCK MANAGEMENT V, LLCVENROCK PARTNERS MANAGEMENT V, LLCVENROCK PARTNERS V, L.P.VHCP CO-INVESTMENT HOLDINGS II, LLCVHCP MANAGEMENT II, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G a18-18097_1sc13g.htm SC 13G 337570
  Complete submission text file 0001104659-18-049177.txt   339365
Mailing Address 3340 HILLVIEW AVENUE PALO ALTO CA 94304
Business Address 3340 HILLVIEW AVENUE PALO ALTO CA 94304 650-475-3734
VENROCK ASSOCIATES V LP (Filed by) CIK: 0001391289 (see all company filings)

IRS No.: 000000000
Type: SC 13G

Mailing Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142 617-714-0555
CONSTELLATION PHARMACEUTICALS INC (Subject) CIK: 0001434418 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90572 | Film No.: 18988237
SIC: 2834 Pharmaceutical Preparations